Quick Nav
News

Antidiabetic Therapies and Their Role in Addressing Glucose Regulation Defects

Published Online: Friday, December 16, 2011

Pharmacy Times Office of Continuing Professional Education

Diabetes Update for Pharmacists: Current and Emerging Antidiabetic Therapies and Their Role in Addressing Glucose Regulation Defects

Nissa Mazzola, PharmD, CGP
Assistant Clinical Professor, Clinical Pharmacy Practice, College of Pharmacy and Allied Health Professions, St. John's University, Queens, New York
Ambulatory Care Specialist, North Shore University Hospital, Manhasset, New York


The third in a 3-part series focusing on diabetes management, this activity will review the therapeutic options to help improve blood sugar in type 2 diabetes, which accounts for 80% to 90% of diabetes cases in the United States. Type 2 diabetes represents several different primary genetic and environmental insults that lead to relative insulin deficiency. A number of therapeutic options are available to address these defects to improve blood sugar levels. This activity will provide a review of the available and emerging pharmacologic treatments and how each medication addresses the numerous metabolic deficits seen in patients with diabetes.

Educational Objectives
Upon completing the program, participants should be able to:
  1. Describe the mechanisms of action of currently available pharmacologic options for the management of type 2 diabetes.
  2. Review the pharmacologic target and outcome associated with each medication.
  3. Examine evidence on emerging antidiabetic agents, their role in diabetes management, and how they will address defects in glucose regulation.
Credits: 2.0
Expiration Date: December 15, 2013

Click here to view this activity.
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-257-0701

Copyright HCPLive 2006-2013
Intellisphere, LLC. All Rights Reserved.
 




Become a Member
Forgot Password?